A convergence of biological risks

The convergence of biological risks stems from a multitude of factors, including AI advancements, biological breakthroughs, high-risk-high-reward research, escalating geopolitical tensions, and a weakened U.S. public health sector. As these trends intensify, the danger of a lethal human-made pathogen emerging, either accidentally or intentionally, grows.

Experts debate the extent of this risk, with some expressing concern that a lab mishap or intentional act could result in a catastrophic biological outbreak. Ashish Jha, the Biden administration's COVID response coordinator, has founded a company to detect emerging biological threats, highlighting the need for greater guardrails.

While the risk of a state-sponsored biological weapon is a concern, Jha believes an accidental lab release is his primary worry. The rise of AI has lowered barriers for some researchers, potentially increasing the likelihood of a lab leak. Despite these concerns, Jha acknowledges that AI can also bolster biodefense efforts. The U.S. intelligence community's annual threat assessment notes that China, North Korea, and Russia likely possess the knowledge and capability to produce and employ traditional biological pathogens and toxins.

AI advancements, nanotechnology, and genomic editing could lead to novel biological threats or raise the potential for safety events resulting in unintended pathogen releases. However, AI remains a valuable tool in responding to pandemics and preventing biological threats.